Avenue Therapeutics' IPO

Avenue Therapeutics raised a round of funding on June 27, 2017. Investors include Public.

Avenue Therapeutics (NASDAQ: ATXI) is a specialty pharmaceutical company that acquires/in-licenses, develops and commercializes products principally for use in the acute/hospital setting.…

Articles about Avenue Therapeutics' IPO: